Mounjaro (Tirzepatide) – Injectable for Weight Loss In Malaysia

Mounjaro is a once-weekly injectable medication designed to help manage type 2 diabetes and support significant weight loss. It combines dual GIP and GLP-1 receptor agonist activity, working to reduce appetite, slow gastric emptying, and improve insulin response. Ideal for patients seeking maximum weight loss and blood sugar control with the convenience of a weekly injection.

Key Benefits:

• Supports weight loss and blood sugar management

• Once-weekly injection for convenience

• Dual-action therapy with GIP + GLP-1 agonist

• Clinically proven for enhanced weight reduction

Important: Treatment should be started and monitored by a doctor. Book a consultation with our team at Klinik Sentosa to find out if Mounjaro is right for you.